METTL3 and colorectal carcinoma: Further, STM2457 treatment suppressed the basal and maximal OCR in 5-FU resistant CRC cells (Figure 2G and H).To confirm the essential roles of METTL3, we knocked down METTL3 in 5-FU resistant CRC cells (Figure 2H).